Simplified use of 5' ends of RNAs for cloning and cDNA library construction

Eberwine, James H. ;   et al.

Patent Application Summary

U.S. patent application number 10/630333 was filed with the patent office on 2004-05-13 for simplified use of 5' ends of rnas for cloning and cdna library construction. Invention is credited to Eberwine, James H., Madison, Roger.

Application Number20040091917 10/630333
Document ID /
Family ID21778077
Filed Date2004-05-13

United States Patent Application 20040091917
Kind Code A1
Eberwine, James H. ;   et al. May 13, 2004

Simplified use of 5' ends of RNAs for cloning and cDNA library construction

Abstract

A method of directional cloning using the 5' ends of RNAs for use, for example, in cloning and cDNA library construction is provided.


Inventors: Eberwine, James H.; (Philadelphia, PA) ; Madison, Roger; (Chapel Hill, NC)
Correspondence Address:
    Licata & Tyrrell P.C.
    66 E. Main Street
    Marlton
    NJ
    08053
    US
Family ID: 21778077
Appl. No.: 10/630333
Filed: July 30, 2003

Related U.S. Patent Documents

Application Number Filing Date Patent Number
10630333 Jul 30, 2003
09194513 Feb 25, 1999
6623965
09194513 Feb 25, 1999
PCT/US97/06957 Apr 25, 1997
60016617 May 1, 1996

Current U.S. Class: 435/6.16 ; 435/91.2
Current CPC Class: C12N 15/1096 20130101
Class at Publication: 435/006 ; 435/091.2
International Class: C12Q 001/68; C12P 019/34

Claims



What is claimed:

1. An improved method of directional cloning of DNA comprising annealing a first oligonucleotide encoding a restriction site to single-stranded (-) cDNAs to create double-stranded regions on the single-stranded (-) cDNA so that regions to be replicated in a second (+) strand synthesis are limited.

2. The method of claim 1 further comprising annealing a second oligonucleotide encoding the restriction site and having a homopolymeric tail complementary to a homopolymeric tail at the 3' end of the single-stranded (-) cDNAs to the 3' end of the single-stranded (-) cDNA strand to form a stable replication competent gapped single-stranded circle by hybridization of the restriction site of the second oligonucleotide to the restriction site of the single-stranded (-) cDNAs.
Description



[0001] This application is a continuation of U.S. Ser. No. 09/194,513 filed Feb. 25, 1999, which is the U.S. National Phase of PCT/US97/06957 filed Apr. 25, 1997, which claims the benefit of U.S. Provisional Application No. 60/016,617 filed May 1, 1996, each of which are herein incorporated by reference in their entireties.

BACKGROUND OF THE INVENTION

[0002] Cloning of DNA sequences encoding expressed proteins and construction of cDNA libraries from poly A+ mRNAs isolated form cells and tissues is currently performed in accordance with procedures outlined in FIGS. 1a and 1b. However, the overall process is very laborious and has several technical limitations. Decreasing activity of the reverse transcriptase enzyme during first strand synthesis of the reverse complementary DNA (-) strand from the mRNA can result in yield of a product that is not full length. In addition, truncations can occur during the second round of synthesis to regenerate the corresponding "sense" coding (+) DNA sequences from the (-) DNA strand. For abundant mRNAs, a complete full length second strand is not always required as there is a greater likelihood for overlapping cDNAs that span a complete coding region. However, for smaller quantities of mRNA a full length strand may be only represented a few times.

[0003] As outlined in FIGS. 1a and 1b, the current procedure also requires homopolymeric tailing of both the cDNA sequences and the restriction digested cloning vectors, thus doubling the amount of manipulation involved. In addition, homopolymeric tailing of the vector results in loss of the original restriction site thereby limiting the ease of subsequent excision of the cloned cDNA region for the transfer to other expression or amplification vectors.

[0004] Accordingly, improvements to simplify cloning of mRNA sequences for use in the cloning of cDNAs for expression of proteins and in the construction of cDNA libraries are desired.

SUMMARY OF THE INVENTION

[0005] In the present invention a simplified method of directional cloning is provided. This method can be used, for example, in the cloning of the 5' ends of cDNAs. The present invention differs from prior art cloning methods requiring homopolymeric tailing of both cDNA sequences and restriction enzyme digested vectors along with complete second strand synthesis before homopolymeric tailing. The method of the present invention improves the efficiency of the cloning of 5'-cDNA ends thereby increasing the likelihood of constructing full-length cDNA libraries comprised of overlapping cDNA subsequences.

[0006] The present invention uses oligonucleotides encoding restriction sites to create local double-stranded regions upon the first strand cDNA product of reverse transcriptase. The double-stranded regions are cleaved by double-strand requiring restriction endonucleases and serve to limit the regions to be replicated in a second (+) strand synthesis. Use of these oligonucleotides also increases the accuracy of replication of the entire shorter (-) cDNA strand to yield more of the 5' (+) cDNA sequences necessary for obtaining a full representation of the entire mRNA coding sequence.

[0007] The method of the present invention also uses an oligonucleotide primer containing the same restriction site that is homopolymerically tailed to complement the homopolymerically tailed 3' end of the (-) cDNA strand. The 5' end of this primer hybridizes to the palindromic complement 3' end of the restriction digested (-) cDNA strand thereby forming a more stable and replication competent gapped single-stranded circle. The resultant double-stranded product contains a unique copy of the targeting restriction site encoded by the priming oligonucleotide. Cleavage at this site yields double-stranded cDNA containing pairs that can be directly ligated into appropriate multiple cloning sites of commercial cloning and expression vectors. Since the restriction site is preserved and flanks the cDNA insert, the desired cDNA sequences can be readily excised and transferred to other vectors if necessary.

BRIEF DESCRIPTION OF THE FIGURES

[0008] FIGS. 1a and 1b are schematics detailing the steps required by prior art procedures used to obtain cDNA clones from poly A+ mRNA. A complete set of clones containing different cDNAs representing all possible coding sequences derived from isolated mRNAs constitute a cDNA library. Regions of RNA, first strand (-) DNA and second strand (+) DNA are indicated by different stippling patterns in the bars. The nucleotide sequences of homopolymeric tailings are indicated in bold type. Steps are numbered sequentially as indicated. Those listed on the left are for preparation of cDNA. Those listed on the right are for preparation of the cloning vector.

[0009] FIGS. 2a, 2b, and 2c are schematics detailing the steps of the method of the present invention when used for obtaining cDNA clones. The left portion of the figures show the method for cDNAs derived from oligo-dT priming. The right portion of the figure shows the method for random priming of the poly A+ mRNA.

DETAILED DESCRIPTION OF THE INVENTION

[0010] The present invention provides a method of directional cloning which uses the 5'-ends of RNAs, for example, to obtain cDNA clones. A detailed schematic of the method of the present invention being used to produce cDNA clones is provided in FIGS. 2a-c. In this embodiment, oligo-dT or random priming of poly A+ mRNA is used to generate (-) first strand cDNAs. These cDNAs are then homopolymerically tailed with dG or dC using terminal deoxynucleotidyl transferase. After tailing, the heteroduplex is denatured by heat and the mRNA removed by alkaline hydrolysis or RNAse digestion to yield single-stranded (-) cDNA. The single-stranded (-) cDNA is the mixed with an first oligonucleotide incorporating a palindromic restriction site in the middle which is flanked on both the 5' and 3' sides with at least two completely degenerate nucleotides. In a preferred embodiment the first oligonucleotide consists of ten bases, including a 6 base palindromic restriction site, such as that for EcoRI, flanked by two degenerative nucleotides, as the ten base overall length allows a high degree of specificity of targeting with reasonable annealing temperature. However, this oligonucleotide can be longer to incorporate other palindromic restriction endonuclease recognition sequences. Examples of restriction endonuclease recognition sequences which can be used include, but are not limited to, BglII, ClaI, EcoRV, SacI, KpnI, SmaI, BamHI, XbaI, SalI, AccI, AvaI, PstI, SphI, HindIII, HincII, NsiI, NotI, SfiI, ApaI, NcoI, StuI, NdeI, PvuII, and XhoI. After mixing, the oligonucleotide-cDNA mixture is slowly cooled from 50.degree. C. to 37.degree. C. and the cognate restriction enzyme is added. The resulting annealed, short double-stranded DNA segments correspond to the positions of these restriction sites on the (-) cDNA. Cleavage by the cognate restriction enzyme yields single-stranded cDNAs bound on their 5' end by the "sticky end" left by the restriction enzyme used and on their 3' end by a poly-dG or -dC tract. Thus, the method of the present invention allows specific site-directed cleavage of the single-stranded (-) cDNA thereby eliminating the need for second strand synthesis of the entire (+) cDNA to provide the double-stranded restriction site as in prior art methods. Accordingly, the present invention is much simpler and requires less time than the prior art methods. Further, considerably smaller amounts of oligonucleotide triphosphate reagents are required.

[0011] A second oligonucleotide comprising nucleotides complementary to the 3' end of the cDNAs and containing the same restriction site as in the first oligonucleotide is then annealed to the 3' poly-dG or -dC tailed single-stranded (-) cDNA by a similar cycle of heating and slow cooling as described above. Since this single-stranded (-) cDNA contains the cognate "sticky end" at its 5' terminus, the 5' end can loop back and also anneal to the second oligonucleotide at the restriction site. The resulting primed and gapped single-stranded (-) cDNA is stabilized and rendered replication-competent for second strand synthesis of (+) cDNA by the addition of a DNA polymerase and DNA ligase. Since the cDNA region to be replicated is shorter than the original full-length sequence, the likelihood of it being completely and accurately replicated is increases over standard methods requiring the traverse of a longer region of (-) cDNA. The resulting double-stranded closed-circular cDNA is readily separated from linear single-stranded fragments and trinucleotides by spin column chromatography or agarose gel electrophoresis.

[0012] In addition, the resultant double-stranded cDNAs are readily linearized with the cognate restriction enzymes to regenerate "sticky ends": compatible for direct ligation into vectors similarly linearized. This eliminates the extra effort in homopolymeric tailing of the vector prior to insertion of the cDNA by prior art methods. Further, the method of present invention preserves the cloning restriction site thus allowing ready excision of the desired cDNA sequences by the same restriction enzyme.

[0013] As will be obvious to those of skill in the art upon reading this disclosure, the directional cloning method of the present can also be used in different embodiments. For example, by utilizing a complete set of oligonucleotides containing the common restriction sites utilized in the multiple cloning sites of plasmid or phage vectors, the present method can be used to provide a complete set of restriction site delimited cDNA sublibraries which would greatly facilitate both cloning and sequence analysis of cDNAs. A mRNA can be effectively scanned for all potential restriction sites thereby ensuring that a cDNA sublibrary would encode the corresponding desired 5' ends for almost all encoded mRNA.

Sequence CWU 1

1

4 1 10 DNA Artificial sequence Synthetic 1 nngaattcnn 10 2 10 DNA Artificial sequence Synthetic 2 nncttaagnn 10 3 11 DNA Artificial sequence Synthetic 3 gaattccccc c 11 4 10 DNA Artificial sequence Synthetic 4 aattcccccc 10

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed